Restasis and Maxair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Maxair (pirbuterol acetate). Common drug interactions include osteoarthritis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Maxair. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Maxair?

Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,903 Maxair users. Check the latest studies of Maxair.

On Jul, 29, 2026

25 people who take Restasis and Maxair together, and have interactions are studied.

What are the common drug interactions of Restasis and Maxair, by gender? *:

female:

Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteomyelitis (infection of bone)
Osteopenia (a condition where bone mineral density is lower than normal)
Therapeutic response decreased (less preventive response)
Therapeutic response unexpected
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Chills (felling of cold)
Hypertension (high blood pressure)
Hyperventilation
Insomnia (sleeplessness)

male:

Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Upper respiratory tract infection

What are the common drug interactions of Restasis and Maxair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Disability
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Influenza like illness
Laryngitis (inflammation of the larynx)
Pyrexia (fever)
Spinal fusion surgery
Therapeutic response unexpected
Upper respiratory tract infection

60+:

Chronic kidney disease
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Injection site mass
Injection site pain
Chills (felling of cold)
Hyperventilation
Pyrexia (fever)
Renal failure (kidney dysfunction)
Tremor (trembling or shaking movements in one or more parts of your body)
Renal tubular necrosis (death of kidney tubules)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 56.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 52.00%
Tooth Abscess (pus formation in tooth): 6 people, 24.00%
Hiv Infection: 6 people, 24.00%
Back Pain: 6 people, 24.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 6 people, 24.00%
Depression: 6 people, 24.00%
Diarrhea: 6 people, 24.00%
Dry Mouth: 6 people, 24.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 24.00%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Maxair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously